InvestorsHub Logo
Followers 39
Posts 2669
Boards Moderated 0
Alias Born 03/14/2017

Re: uvaphd post# 110046

Thursday, 08/05/2021 1:45:08 PM

Thursday, August 05, 2021 1:45:08 PM

Post# of 111073
Yes, they've diverged some, however I was referring to the commonality of Dr. Thomas Ichim mostly, and if he's gaining approvals from the FDA on JadiCell, he's likely having discussions about ImmCelz and MyeloCelz as well. I would not be surprised to hear about approvals for these in the near future.

Though I agree that TSOI is much farther along and has an advantage at the moment.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CELZ News